Sean Fortier is a Respiratory physician affiliated with University of Michigan. OpenAlex indexes 28 publications with 411 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
78.4%Corticosteroid43.2%Trelegy Ellipta46%Symbicort20%Budesonide-Formoterol Fumarate13%Breyna11%Fluticasone Propionate10%Part D<11 patientsbeta2-Adrenergic Agonist29.5%Albuterol Sulfate Hfa100%Part D≥23 patients+ 1 more class in this area
Anti-infectives
12%Macrolide Antimicrobial12%Azithromycin100%Part D<11 patientsMetabolism & gastrointestinal
5.1%Corticosteroid5.1%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2023–2025 per NIH RePORTER. The latest:
- Lung Myofibroblast De-Differentiation and Fibrosis Resolution Depend on cAMP-mediated Inhibition of HuR.
University of Michigan at Ann Arbor
FY2025$169,560K08HL163178 - Lung Myofibroblast De-Differentiation and Fibrosis Resolution Depend on cAMP-mediated Inhibition of HuR.
University of Michigan at Ann Arbor
FY2024$169,560K08HL163178 - Lung Myofibroblast De-Differentiation and Fibrosis Resolution Depend on cAMP-mediated Inhibition of HuR.
University of Michigan at Ann Arbor
FY2023$169,560K08HL163178
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Justin Oldham, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Eva Feldman, MD
University of Michigan
Justin Oldham, MD
University of Michigan
Fernando Martinez, MD
University of Massachusetts Chan Medical School
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”